Lazarini has 25 years of experience in the pharmaceutical sector and his foray into the industry happened by accident. As a graduate in administrative computing, he was part of the technical support team in a transnational pharmaceutical laboratory, however, his interest in the service and his ease of analysis, together with his virtue in relating to his partners, made him integrate into commercial areas. , trade marketing and development of new businesses in the ethical, generic, private label and OTC consumer markets. Finally, in 2018 he came to Somar with the intention of finding professional growth in the company.
According to the manager, visualizing, preparing and executing comprehensive business plans with Somar’s partners and clients have helped him identify different areas of opportunity that have brought significant growth results. In other words, “the market in Mexico behaves differently both territorially and in the different distribution channels, so you have to design and implement tailored suits,” he said.
Vision for the future is necessary
As a leader you must give your collaborators the opportunity to develop professionally and serve as a guide, direct them, even offer them new approaches to address the challenges of everyday life. Over time, he confirmed that teamwork generates innovative and powerful proposals. He comments that one of his main objectives is “to grow above the market and what our clients grow”.
EXPANSION: What has been the position of the group regarding the transformation of the business within a diversity of markets and channels?
Louis Lazarini: We have several business units within the Group and each of them allows us to focus our efforts and adapt to very different markets.
we got lakeside® as a prescription business unit with medical representatives for the therapeutic areas of antibiotics, anti-infectives and pain, mainly.
Advaita® Pharmaceuticals is our dermatology business unit where we serve, in the same way, through medical representatives. The products focus on therapeutic areas such as severe acne, atopic dermatitis, scarring, and alopecia.
Serral Laboratories®; gel caps®Quifa®Pharmacaps® and Diba® They aim directly at the generic market, with products where Somar puts its own brand. Others we manufacture for pharmacy and self-service chains in the country, with a very robust portfolio.
Additionally, the group is present in the digital market with commercial partners to manage various promotions and we have key allies that help us put high-quality products in pharmacies and within the reach of patients.